sunny.png
Friday November 27th, 2020 11:34AM

Oxford, AstraZeneca resumes coronavirus vaccine trial

By The Associated Press
Related Articles
  Contact Editor

LONDON (AP) — Oxford University announced Saturday it was resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was suspended following a reported side-effect in a U.K. patient.

In a statement, the university confirmed the restart across all of its U.K. clinical trial sites after regulators gave the go-ahead following the pause on Sunday.

“The independent review process has concluded and following the recommendations of both the independent safety review committee and the U.K. regulator, the MHRA, the trials will recommence in the U.K.,” it said.

The vaccine being developed by Oxford and AstraZeneca is widely perceived to be one of the strongest contenders among the dozens of coronavirus vaccines in various stages of testing around the world.

British Health Secretary Matt Hancock welcomed the restart, saying in a tweet that it was “good news for everyone” that the trial is “back up and running.”

The university said in large trials such as this “it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety.”

It said globally some 18,000 people have received its vaccine so far in Britain, Brazil and South Africa. Around 30,000 volunteers are being recruited in the U.S.

Although Oxford would not disclose information about the patient's illness due to participant confidentiality, an AstraZeneca spokesman said earlier this week that a woman had developed severe neurological symptoms that prompted the pause. Specifically, the woman is said to have developed symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord.

The university insisted that it is “committed to the safety of our participants and the highest standards of conduct in our studies and will continue to monitor safety closely.”

Pauses in drug trials are commonplace and the temporary hold led to a sharp fall in AstraZeneca's share price following the announcement Tuesday.

The Oxford-AstraZeneca study had been previously stopped in July for several days after a participant developed neurological symptoms that turned out to be an undiagnosed case of multiple sclerosis that researchers said was unrelated to the vaccine.

During the third and final stage of testing, researchers look for any signs of possible side effects that may have gone undetected in earlier patient research. Because of their large size, the studies are considered the most important study phase for picking up less common side effects and establishing safety. The trials also assess effectiveness by tracking who gets sick and who doesn’t between patients getting the vaccine and those receiving a dummy shot.

Dr. Charlotte Summers, a lecturer in intensive care medicine at the University of Cambridge, said the pause was a sign that the Oxford team was putting safety issues first, but that it led to “much unhelpful speculation.”

“To tackle the global COVID-19 pandemic, we need to develop vaccines and therapies that people feel comfortable using, therefore it is vital to maintaining public trust that we stick to the evidence and do not draw conclusions before information is available,” she said.

Scientists and others around the world, including experts at the World Health Organization, have sought to keep a lid on expectations of an imminent breakthrough for coronavirus vaccines, stressing that vaccine trials are rarely straightforward.

Italy’s health minister, Roberto Speranza, welcomed the resumption of the vaccine trial, but warned that prudence was still necessary.

“Science is at work to give the world efficient and secure treatments and vaccines,” he said. “In the meantime, the key continues to be our behavior.”

Italy, which was ground zero for Europe's outbreak, is one of the main countries investing in the AstraZeneca vaccine.

Two other vaccines are in huge, final-stage tests in the United States, one made by Moderna Inc. and the other by Pfizer and Germany’s BioNTech.

___

Nicole Winfield in Rome contributed.

___

Follow AP’s pandemic coverage at http://apnews.com/VirusOutbreak and https://apnews.com/UnderstandingtheOutbreak

  • Associated Categories: Associated Press (AP), AP National News, AP Online National News, Top General short headlines, AP Health, AP World News, AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care
© Copyright 2020 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Oxford, AstraZeneca resumes coronavirus vaccine trial
Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the U_K_ The university said in large trials such as this “it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety.”
12:22PM ( 4 minutes ago )
Pence drops plan to go to fundraiser hosted by QAnon backers
Vice President Mike Pence has canceled plans to attend a Montana fundraiser for the Trump campaign following revelations that the event's hosts have expressed support for the QAnon conspiracy theory
12:21PM ( 4 minutes ago )
French yellow vest march has lukewarm relaunch after virus
Activists have relaunched France’s yellow vest movement after the disruptive demonstrations against French President Emmanuel Macron tapered off during the coronavirus pandemic
12:17PM ( 8 minutes ago )
Associated Press (AP)
Oxford, AstraZeneca to resume coronavirus vaccine trial
Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the U_K_ The university said in large trials such as this “it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety.”
10:57AM ( 1 hour ago )
Trump looks west, eyeing new paths to White House
President Donald Trump is pushing to expand his electoral map as he makes a trip west this weekend
10:33AM ( 1 hour ago )
Iran executes man whose case drew international attention
Iran’s state TV is reporting that the country’s authorities have executed a wrestler for allegedly murdering a man
10:03AM ( 2 hours ago )
AP National News
Dozens still missing in Oregon as weather helps fire fight
A change in the weather — with winds easing and humidity rising — have helped firefighters battling massive blazes in Oregon that have taken a deadly toll from one end of the state to the other
5:50AM ( 6 hours ago )
Thousands still homeless after Greek refugee camp fire
Thousands of asylum-seekers spent a fourth night sleeping in the open on the Greek island of Lesbos, after successive fires destroyed the notoriously overcrowded Moria camp during a coronavirus lockdown
4:21AM ( 8 hours ago )
Crews battling California fires head to devastated areas
Smoke from massive wildfires that painted skies throughout California orange is helping crews struggling to surround the deadliest blaze of the year
2:08AM ( 10 hours ago )
AP Online National News
Collins won't say in debate who she'll vote for in November
Democrat Sara Gideon sought to link Republican Sen. Susan Collins of Maine with President Donald Trump during their first debate
10:19PM ( 14 hours ago )
Amid ashes, California governor fires away on climate change
California’s governor is offering some of his most impassioned comments yet on the dangers of climate change
10:01PM ( 14 hours ago )
Autopsy report: Naya Rivera called for help as she drowned
An autopsy report says “Glee” actor Naya Rivera raised her arm and called for help as she accidentally drowned while boating with her 4-year-old son on a California lake
9:31PM ( 14 hours ago )
Top General short headlines
Trump's virus debate: Project strength or level with public
President Donald Trump is trying to place himself in the company of Franklin Roosevelt and Winston Churchill as he assesses his response to the coronavirus pandemic
11:09AM ( 1 hour ago )
Turkey's Erdogan slams Macron amid Mediterranean tensions
Turkey’s president has slammed France’s president, following French criticism on Turkish maritime activities in the eastern Mediterranean
10:32AM ( 1 hour ago )
Thousands march in Mauritius to protest disastrous oil spill
Thousands of people have protested again in Mauritius over the government’s handling of an offshore oil spill that became the Indian Ocean island nation’s worst environmental disaster in years
9:54AM ( 2 hours ago )
AP Business
Swiss court puts Qatari on trial in soccer case next week
A criminal trial opens Monday in the Swiss investigation of FIFA and international soccer officials
12:31PM ( 23 hours ago )
Hyundai warns owners to park outside, recalls 180,000 SUVs
For the second time this month, Hyundai is telling some SUV owners to park outdoors because an electrical short in a computer can cause vehicles to catch fire
11:56AM ( 1 day ago )
Drone maker hurt by US-China rift, opening door to US rivals
U.S. national security concerns about the world’s dominant consumer drone-maker, China-based DJI, have upended the market for small drones
10:13AM ( 1 day ago )
AP Business - Corporate News
COVID beds fill up as virus pressure builds in Marseille
All five intensive care beds dedicated to COVID patients are full in the Laveran Military Training Hospital in Marseille, and its doctors are bracing for more
1:33PM ( 22 hours ago )
The Latest: South Korea stays in downward infection trend
South Korea’s daily count of new coronavirus cases is under 200 for a ninth straight day, continuing a downward trend in fresh infections for the country
11:05PM ( 1 day ago )
The Latest: New Orleans keeps tough virus rules, state eases
New Orleans will not follow the rest of Louisiana in easing up on public gathering restrictions aimed at preventing the spread of the coronavirus
7:55PM ( 1 day ago )
AP Business - Industries
The Latest: WHO scientist: Trial suspension a 'wake-up call'
The World Health Organization’s chief scientist says the agency isn’t overly worried about the pause in the clinical trials for a coronavirus vaccine developed by Oxford University and AstraZeneca
1:06PM ( 1 day ago )
The Latest: India vaccine clinical trials halted for safety
Clinical trials for AstraZeneca’s coronavirus vaccine candidate have been halted in India, according to the Serum Institute of India
8:42AM ( 2 days ago )
Vaccine by Nov. 3? Halted study explains just how unlikely
The National Institutes of Health director is telling Congress that AstraZeneca's suspension of its COVID-19 vaccine study shows there will be “no compromises” on safety in developing the shots
6:13PM ( 2 days ago )
AP Business - Health Care
Pence drops plan to go to fundraiser hosted by QAnon backers
Vice President Mike Pence has canceled plans to attend a Montana fundraiser for the Trump campaign following revelations that the event's hosts have expressed support for the QAnon conspiracy theory
12:21PM ( 5 minutes ago )
French yellow vest march has lukewarm relaunch after virus
Activists have relaunched France’s yellow vest movement after the disruptive demonstrations against French President Emmanuel Macron tapered off during the coronavirus pandemic
12:17PM ( 9 minutes ago )
Antarctica is still free of COVID-19. Can it stay that way?
Antarctica remains the only continent without COVID-19
12:01PM ( 25 minutes ago )
The Latest: Oxford Univ will resume trials of virus vaccine
Oxford University says trials of a coronavirus vaccine its developing with pharmaceutical company AstraZeneca will resume, days after pausing due to a reported side effect in a patient in Britain
11:52AM ( 34 minutes ago )
Better weather aids battle against deadly Western wildfires
Diminishing winds and rising humidity are helping firefighters battling deadly blazes in Oregon and California
11:29AM ( 57 minutes ago )